Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies.
Interleukin-10 (IL-10)-deficient (IL-10(-/-)) mice infected with Plasmodium chabaudi (AS) suffer a more severe disease and exhibit a higher rate of mortality than control C57BL/6 mice. Here, we show that a drop in body temperature to below 28 degrees C and pronounced hypoglycemia of below 3 mM are reliable indicators of a lethal infection. Elevated inflammatory responses have been shown to accompany pathology in infected IL-10(-/-) mice. We show that neutralization of tumor necrosis factor alpha (TNF-alpha) in IL-10(-/-) mice abolishes mortality and ameliorates the hypothermia, weight loss, and anemia but does not affect the degree of hypoglycemia. These data suggest that TNF-alpha is involved in some of the pathology associated with a P. chabaudi infection in IL-10(-/-) mice but other factors play a role. IL-10(-/-) mice that survive a primary infection have been shown to control gamma interferon (IFN-gamma) and TNF-alpha production, indicating that other cytokines or mechanisms may be involved in their down-regulation. Significantly higher levels of transforming growth factor beta (TGF-beta), a cytokine with such properties, are present in the plasma of infected IL-10(-/-) mice at a time that coincides with the disappearance of IFN-gamma and TNF-alpha from the blood. Neutralization of TGF-beta in IL-10(-/-) mice resulted in higher circulating amounts of TNF-alpha and IFN-gamma, and all treated IL-10(-/-) mice died within 12 days with increased pathology but with no obvious increase in parasitemia. Our data suggest that a tight regulation of the balance between regulatory cytokines such as IL-10 and TGF-beta and inflammatory cytokines such as IFN-gamma and TNF-alpha is critical for survival in a mouse malaria infection.
Item Type | Article |
---|---|
Keywords | Animal, Antibodies/pharmacology, Female, Inflammation Mediators/antagonists & inhibitors/blood, Interferon Type II/blood, Interleukin-10/*deficiency/genetics/physiology, Malaria/etiology/*immunology/*pathology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Neutralization Tests, *Plasmodium chabaudi, Support, Non-U.S. Gov't, Transforming Growth Factor beta/*antagonists & inhibitors/blood, Tumor Necrosis Factor/*antagonists & inhibitors/metabolism, Animal, Antibodies, pharmacology, Female, Inflammation Mediators, antagonists & inhibitors, blood, Interferon Type II, blood, Interleukin-10, deficiency, genetics, physiology, Malaria, etiology, immunology, pathology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Neutralization Tests, Plasmodium chabaudi, Support, Non-U.S. Gov't, Transforming Growth Factor beta, antagonists & inhibitors, blood, Tumor Necrosis Factor, antagonists & inhibitors, metabolism |
ISI | 184996600004 |
Explore Further
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC187303 (OA Location)
- 10.1128/IAI.71.9.4850-4856.2003 (DOI)
- 12933825 (PubMed)